Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL2023 · 145 citations
2. 2Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial2022 · 239 citations
3. 3P366: BLINATUMOMAB ADDED TO PREPHASE AND CONSOLIDATION THERAPY IN NEWLY DIAGNOSED PRECURSOR B-ALL IN ADULTS. A PHASE II HOVON TRIAL2022 · 16 citations
4. 4Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology2017 · 135 citations
5. 5A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias2013 · 1,124 citations